DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole fumarate), a Novel Derivative of Ibogamine, Inhibits α7 and α9α10 Nicotinic Acetylcholine Receptors by Different Allosteric Mechanisms (Tae et al.)

Published: Jun 29, 2023
ACS Chem. Neurosci.

~

Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review (Lee et al.)

Published: Jun 29, 2023
Journal of Psychoactive Drugs

~

Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA (Haug et al.)

Published: Jun 29, 2023
Journal of Psychoactive Drugs

~

(News) Australia to prescribe MDMA and psilocybin for PTSD and depression in world first (Haridy)

Published: Jun 30, 2023
Nature

~

AJA Psychedelics ad

Published: Jun 29, 2023
The American Journal on Addictions

~

On Redescribing the Indescribable: Trauma, Psychoanalysis and Psychedelic Therapy (Modlin et al.)

Published: Jun 30, 2023
British Journal of Psychotherapy